GST Benefits New Revised MRP, 100% GST benefit passed
Notify Me
Innovative Pharmaceuticals Pvt Ltd

BOXTAG 1.125gm Injection 10ml

Bacterial Infections
MRP ₹99.55 (Inclusive of all taxes)
Deliver to

    Netmeds First Membership

    Starting at just ₹[] for 3 months.
    View Plans

    Introduction About BOXTAG 1.125GM INJECTION

    BOXTAG 1.125GM INJECTION is a combination of Piperacillin and Tazobactam which belongs to the group of medicines called Antibiotics. It is used to manage several bacterial infections such as lower respiratory tract infections such as pneumonia, acute bacterial exacerbation causing breathing difficulties, urinary tract infections, pyelonephritis, skin infections, abdominal, biliary tract infections and female pelvic infections such as postpartum endometritis or pelvic inflammatory disease, bacteraemia, and bacterial meningitis in infants and children.

    It is also used along with other antibacterial agents in the management of neutropenic caused by bacterial infection.

    Pneumonia is an infection which causes inflammation in the air sac producing cough with phlegm and shortness of breath. Pyelonephritis is a urinary tract infection affecting the urinary bladder later gets spreads to the kidneys. Bacteraemia is an infectious condition indicating presence of bacteria in the blood stream.

    Bacterial meningitis is an infection caused by bacteria in the region surrounding the brain. Neutropenic is low levels of neutrophils (a type of white blood cells) in our body.

    Kindly inform your doctor or your health-care professional before any laboratory tests as BOXTAG 1.125GM INJECTION will interact with medical investigations. Inform your doctor if you are allergic to any antibiotics or other medicines.

    BOXTAG 1.125GM INJECTION should not be used in patients allergic to penicillin antibiotics, cephalosporin, and other beta-lactam antibiotics.

    BOXTAG 1.125GM INJECTION should be used with caution in patients with pre-existing diarrhoea, low potassium levels, kidney, and liver diseases.

    Avoid concomitant use of other aminoglycoside antibiotics and vancomycin along with this medicine.

    BOXTAG 1.125GM INJECTION should be used with caution in pregnant and breast-feeding women. BOXTAG 1.125GM INJECTION should be used with caution in children above 2 months and in elderly people. Your doctor will administer the right dose depends on your child’s age, body weight and severity of the infection.

    The common side effects of BOXTAG 1.125GM INJECTION are diarrhoea, yeast infection, headache, sleeplessness, stomach pain, vomiting, nausea, constipation, skin rash, itching, fever, and injection site reaction.

    Uses Of BOXTAG 1.125GM INJECTION

    It is used to manage the following infections:

    • intra-abdominal infection such as appendicitis and peritonitis
    • skin and skin structure infection such as cutaneous abscesses, cellulitis, diabetic foot
    • female pelvic infections such as postpartum endometritis or pelvic inflammatory disease
    • lower respiratory tract infection such as community-acquired pneumonia, and ventilator-associated pneumonia
    • bacterial septicaemia

    How BOXTAG 1.125GM INJECTION Works

    BOXTAG 1.125GM INJECTION works by destroying the bacterial growth responsible for causing infections. Piperacillin works by interrupting the cell wall formation by binding with the enzymes responsible for cell wall synthesis. This binding causes defects in the cell wall leading to cell death causing death of the organism. Tazobactam is responsible for the irreversible termination of enzymes (beta- lactamases) that protect the organism from antibiotics and produces less anti-bacterial actions when given alone so it’s always used in combination with other antibiotics. Thus, both the substances works by managing cell growth and function inhibiting bacterial growth.

    How to use BOXTAG 1.125GM INJECTION

    BOXTAG 1.125GM INJECTION will be administered into the vein (intravenously) by your doctor or nurse. Your doctor will administer the correct dose and duration for you depending upon your age, body weight and disease condition.

    Side Effects Of BOXTAG 1.125GM INJECTION

    Common

    • diarrhoea
    • yeast infection
    • headache
    • sleeplessness
    • stomach pain, vomiting, nausea, constipation
    • skin rash, itching
    • fever, injection site reaction

    Uncommon

    • low blood pressure
    • inflammation of the veins
    • skin redness, skin lesions
    • joint and muscle pain
    • chills
    • hypokalaemia, breathing difficulty
    • abnormal lab investigations

    Rare

    • lack of white blood cells (agranulocytosis), bleeding nose
    • serious infection of colon
    • inflammation of inner lining of mouth
    • peeling of skin

    Contact your immediately if you experience any of the following side effects after receiving BOXTAG 1.125GM INJECTION

    • serious skin rashes appear as reddish target-like spots or circular patches often with blisters,) ulcers in mouth, throat, nose, extremities, genitals red and swollen eyes (Stevens-Johnson syndrome, dermatitis bullous, dermatitis exfoliative, toxic epidermal necrolysis)
    • a potentially fatal allergic condition (drug reaction with eosinophilia and systemic symptoms) involving skin and other organs such as the kidney and liver
    • skin condition (acute generalised exanthemata’s pustulosis) symptoms include numerous tiny fluids filled blisters with swollen and reddened skin
    • swelling of the face, lips, tongue or other parts of the body, shortness of breath, wheezing or trouble breathing (angioedema)
    • yellowing of the eyes or skin (jaundice)
    • convulsions
    • decrease in blood cells
    • severe diarrhoea with fever

    How To Manage Side Effects

    Diarrhoea:

    Drinking plenty of water and other electrolyte balanced fluids. Make sure to hydrate throughout the day. Do not consume any medicine on your own without consulting your doctor. If the symptom does not improve, contact your doctor.

    Headache:

    Take some rest, in a quiet place avoid using user mobile phones and other electronic devices for a while. Drink enough amount of water, dehydration may lead you to develop a headache. If the symptom does not improve, contact your doctor.

    Nausea or Vomiting:

    Drink clear or ice-cold drinks. Eat light, bland foods. Avoid fried, greasy, or sweet foods.  Eat slowly and eat smaller, more frequent meals, drinking gradually larger amounts of clear liquids, avoid solid food until the vomiting episode has passed, take rest. If the symptom does not improve, contact your doctor.

    Stomach pain:

    Some diet and lifestyle changes can help with stomach pain. Eat smaller portions of meal. Chew your food well and eat slowly. Avoid foods that cause gas or indigestion. Avoid consumption of alcohol and caffeine.

    Inflammation at injection site:

    Try using warm water compress to reduce swelling. Keeping the affected area elevated can help reduce the swelling. Not applying pressure to the affected area will help reducing pain and managing further damage.

    Warning & Precautions

    Pregnancy

    BOXTAG 1.125GM INJECTION should be used with caution in pregnant women. Consult your doctor before receiving the medicine.

    Breastfeeding

    BOXTAG 1.125GM INJECTION should be used with caution in breast-feeding women. Consult your doctor before receiving the medicine.

    Driving and Using Machines

    Do not drive or handle heavy machines if you experience dizziness, drowsiness, tired, or if you have blurred vision while receiving BOXTAG 1.125GM INJECTION.

    Alcohol

    Consumption of alcohol is not recommended during management with BOXTAG 1.125GM INJECTION.

    Kidney

    BOXTAG 1.125GM INJECTION should be used with caution in patients with kidney diseases and patients on haemodialysis. Consult your doctor before receiving the medicine.

    Liver

    BOXTAG 1.125GM INJECTION should be used with caution in patients with liver diseases and patients with abnormal liver tests.  Consult your doctor before receiving the medicine.

    Allergy

    Do not receive BOXTAG 1.125GM INJECTION if you are allergic to Piperacillin or Tazobactam or to any other ingredients of this medicine.

    Lungs

    BOXTAG 1.125GM INJECTION should be used with caution in patients with community-acquired pneumonia and ventilator-associated pneumonia. Consult your doctor before receiving the medicine.

    Others

    Before receiving this medicine inform your doctor if you:

    • are suffering from diarrhoea
    • have low levels of potassium

    Use in pediatrics:

    BOXTAG 1.125GM INJECTION should be used with caution in children above 2 months of age. Your doctor will administer the right dose depends on your child’s age, body weight and disease condition. Consult your doctor before receiving the medicine.

    Use in geriatrics:

    BOXTAG 1.125GM INJECTION should be used with caution in elder patients (above 65 years of age). Consult your doctor before receiving the medicine.

    Interactions

    A. Drug-Drug interactions:

    Before receiving BOXTAG 1.125GM INJECTION, inform your doctor if you are taking any of the following medicine:

    • other antibiotics used to manage bacterial infections (Ex. gentamycin, streptomycin, neomycin, amikacin, vancomycin)
    • medicine used to manage gout (Ex. Probenecid)
    • medicine used as muscle relaxants during surgery (Ex. vecuronium)
    • medicines used to manage blood clots (Ex. heparin, warfarin, aspirin)
    • methotrexate (used to manage cancer, arthritis, or psoriasis)
    • medicines reducing potassium levels (Ex. furosemide)

    Overdosage:

    It is unlikely to receive overdose since it will be administered by the doctor or nurse. If you experience any unusual side effects, consult your doctor immediately. Symptoms of overdose may occur such as nausea, vomiting, diarrhoea, neuromuscular disorders and convulsions.

    Synopsis

    Drug :   Piperacillin, Tazobactam
    Pharmacological Category :   Beta-lactam antibiotics, Beta-lactamase inhibitors
    Therapeutic Indication :   Bacterial infections      
    Dosage Forms :   Injection

    More Information

    • Keep BOXTAG 1.125GM INJECTION out of reach of children
    • Store at room temperature

    FAQs About BOXTAG 1.125GM INJECTION

    Will BOXTAG 1.125GM INJECTION manage different bacterial infections?

    Yes, BOXTAG 1.125GM INJECTION is used in cases of serious infections of chest, urinary system and blood along with others.

    Can BOXTAG 1.125GM INJECTION be used in children?

    Yes, it is safe to use BOXTAG 1.125GM INJECTION in children above 2 months of age, dose adjustments are necessary while used in children. Your doctor will administer the correct dose for your child depending on your child’s age, body weight and disease condition.

    How will BOXTAG 1.125GM INJECTION manage my infection?

    BOXTAG 1.125GM INJECTION works by destroying the bacterial growth responsible for causing infections. Piperacillin works by interrupting the cell wall formation by binding with the enzymes responsible for cell wall synthesis. This binding causes defects in the cell wall leading to cell death causing death of the organism. Tazobactam is responsible for the irreversible termination of enzymes (beta- lactamases) that protect the organism from antibiotics and produces less anti-bacterial actions when given alone so it’s always used in combination with other antibiotics. Thus, both the substances works by managing cell growth and function inhibiting bacterial growth.

    How long will BOXTAG 1.125GM INJECTION take to manage bacterial infections?

    BOXTAG 1.125GM INJECTION will start working once it is injected in the blood stream. It will work faster compared with oral antibiotics as it is injected directly into the blood stream. However full course of antibiotic should be given to obtain its efficacy. Your doctor will decide the dose adjustments and termination of the medicine depending upon your health condition.

    References

    1. K.D. Tripathi Beta-Lactam Antibiotics Page no -724, 725 Essentials of Pharmacology seventh edition Page no: 637.

    2. Alfred Gin, Leanne Dilay, James A Karlowsky,  Andrew Walkty, Ethan Rubinstein, George G Zhanel Piperacillin–tazobactam: a β-lactam/β-lactamase inhibitor combination Taylor Francis online, January 2014 [Accessed on 25th May 2022] https://www.tandfonline.com/doi/abs/10.1586/14787210.5.3.365?journalCode=ierz20

    3. Pfizer, U.S. Food & Drug Administration [Revised on May 2017], [Accessed on 25th May 2022] https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/050684s88s89s90_050750s37s38s39lbl.pdf

    4. Wockhardt UK Ltd, Electronic Medicines Compendium (EMC) [Revised on May 2022] [Accessed on 25th May 2022] https://www.medicines.org.uk/emc/product/6526/smpc#ORIGINAL

    5. Biocon Biologics India Limited, [Revised on September 2019] [Accessed on 25th May 2022] https://www.biocon.com/docs/domestic-market-pi/ccd/BIOPIPER%20TZ%20-PI.pdf

    6. Cipla House, [Revised on May 2021] [Accessed on 25th May 2022] https://ciplamed.com/print-product-pdf/37119

    Author Details

    Written By Dr. Janet.C - Pharm.D
    Reviewed For Accuracy By Dr. Salem Gill - MBBS
    Last updated on 16 Nov 2022 | 12:54 PM(IST)
    Lab updated